Showing results (41-50 of 764) with videos related to
Sort By:
Pageof 77
Cancer|March 18, 2010
Durable responses with the metronomic rituximab and thalidomide plus prednisone, etoposide, procarbazine, and cyclophosphamide regimen in elderly patients with recurrent mantle cell lymphomaJia Ruan, Peter Martin, Morton Coleman, et al.Cell Cycle (Georgetown, Tex.)|May 17, 2013
Induction of prolonged early G1 arrest by CDK4/CDK6 inhibition reprograms lymphoma cells for durable PI3Kδ inhibition through PIK3IP1David Chiron, Peter Martin, Maurizio Di Liberto, et al.Cancer|July 29, 2010
Phase 1 trial of bortezomib plus R-CHOP in previously untreated patients with aggressive non-Hodgkin lymphomaRichard R Furman, Peter Martin, Jia Ruan, et al.International Journal of Cancer|March 25, 2006
Proteasome inhibition with bortezomib: a new therapeutic strategy for non-Hodgkin's lymphomaJohn P Leonard, Richard R Furman, Morton ColemanCurrent Treatment Options in Oncology|July 6, 2004
Epratuzumab in non-Hodgkin's lymphomasRichard R Furman, Morton Coleman, John P LeonardBlood|February 28, 2025
The Future of Follicular Lymphoma Management: Strategies on the HorizonErin Mulvey, Sarah C Rutherford, John P LeonardClinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Activities of SYK and PLCgamma2 predict apoptotic response of CLL cells to SRC tyrosine kinase inhibitor dasatinibZibo Song, Pin Lu, Richard R Furman, et al.Journal of Neurophysiology|August 20, 2010
Phosphorylation-state-dependent regulation of NMDA receptor short-term plasticity modifies hippocampal dendritic Ca2+ transientsDebika Chatterjea, Edaeni Hamid, John P Leonard, et al.Hematology. American Society of Hematology. Education Program|December 4, 2018
Sequencing of therapies in relapsed follicular lymphomaLoretta J Nastoupil, Christopher R Flowers, John P LeonardJournal of Diabetes Science and Technology|April 30, 2011
Pilot study of Aurora, a social, mobile-phone-based emotion sharing and recording systemGeri Gay, Jp Pollak, Phil Adams, et al.Pageof 77